WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gregory M. WeinhoffChief Business Officer2025-06-2510,000$13.86
$138.64kSell
Gregory M. WeinhoffChief Business Officer2025-06-2510,000$3.85
$38.50kBuy
Mario Alberto AccardiPresident Orexin Program2025-06-2415,000$3.85
$57.75kBuy
Mario Alberto AccardiPresident Orexin Program2025-06-2415,000$14.00
$210.00kSell
Iqbal J. HussainGeneral Counsel2025-06-2412,000$14.02
$168.22kSell
Iqbal J. HussainGeneral Counsel2025-06-2412,000$5.84
$70.08kBuy
Saurabh SahaChief Executive Officer2025-06-2055,000$12.63
$694.82kSell
Saurabh SahaChief Executive Officer2025-06-2055,000$3.85
$211.75kBuy
Gregory M. WeinhoffChief Business Officer2025-05-2710,000$12.82
$128.22kSell
Gregory M. WeinhoffChief Business Officer2025-05-2710,000$3.85
$38.50kBuy

1 of 11

CNTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd14.94%19,963,157$270.70MInstitution
Index Venture Life Associates VI Ltd7.46%9,961,789$135.08MInstitution
Gap Bermuda Ltd7.25%9,681,818$131.29MInsider
General Atlantic LP7.25%9,681,818$131.29MInstitution
Adage Capital Partners GP LLC5.20%6,954,000$94.30MInstitution
Janus Henderson Group PLC4.43%5,922,486$80.31MInstitution
Price T Rowe Associates Inc4.00%5,342,344$72.44MInstitution
First Light Asset Management LLC3.65%4,874,124$66.09MInstitution
Farallon Capital Management LLC3.24%4,334,318$58.77MInstitution
Avoro Capital Advisors LLC3.03%4,050,000$54.92MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA90.04%9.96%Net SellingNet Buying
BCRX82.41%17.59%Net SellingNet Buying
SRPT75.10%24.90%Net BuyingNet Buying
IRON56.33%43.67%Net SellingNet Buying
ADPT63.22%36.78%Net SellingNet Selling
View Top Biotech Stocks

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 93.49% institutional shareholders, 10.34% Centessa Pharmaceuticals insiders, and 0.00% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 7.25% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $135.84M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.